88.8% on a lipid-lowering drug (in most cases a statin). Roughly speaking, the percentage of patients on each medication increased significantly from the first to the second survey and from the second to the third. The most recent data indicate that the majority of patients were following a drug regime similar to what is recommended by the ESC guidelines (see Table 3 ).
Although these patients were apparently following a correct drug regime and the global picture was better in the third edition than in the two earlier surveys, the clinical outcomes in terms of risk factor control were far from what was expected: only 53.8% of patients had a cholesterol level below 4.5mmol/l, 39.1% had appropriate blood pressure levels and 81.2% self-reported as non-smokers. The clinical situation was worst in the last survey in terms of reported diabetes (28.0%) and prevalence of overweight (82.7%) and obesity (38%), suggesting that patients are not being compliant to lifestyle measures such as diet and physical activity.
The failure of these high-cost and intensive drug regimes to control the classic risk factors confirms that medication alone is not sufficient and that it is thus necessary to promote the adoption of a healthy lifestyle to reach therapeutic targets. In particular, physical inactivity and obesity must be addressed to counteract their malignant consequences on global and cardiovascular mortality, which increases in all age groups and in both genders when body mass index (BMI) passes 27. Tuhomileto and co-workers, 10 It must be recognised that in everyday clinical practice, healthy behaviour changes are not actively promoted or professionally supported. There is a huge need and potential for increasing smoking cessation rates, diet change and regular physical activity.
The Role of Cardiac Rehabilitation in Achieving Optimal Treatment higher rates of reduction in programmes where exercise was the cornerstone compared with a comprehensive approach or risk factor control programmes (see Table 4 ). This is understandable considering the anti-atherosclerotic, anti-ischaemic, antithrombotic and antiarrhythmic proprieties of regular aerobic training. 28, 29 In the past there was some concern about the risk of ventricular remodelling, which vanished in 2003 after the publication of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHD) study, 30 whose findings were confirmed by Haykowsky's meta-analysis, 31 in which aerobic training reduced ventricular remodelling and resistance training had a neutral effect.
Another matter of concern was the risk of re-infarction and sudden death secondary to the exercise programme. In the French registry, 32 published in 2006, there were no fatal events during exercise sessions or exercise stress tests in more than 25,000 patients from 65 centres.
These figures are similar to those found in previous studies. 33 The Global Secondary Prevention Strategies to Limit Event Recurrence after Myocardial Infarction (GOSPEL) study, 34 cholesterol and triglycerides), higher rates of smoking discontinuation, lower systolic blood pressure and lower BMI.
Concerning drug therapy, the intervention group showed greater adherence to guideline medication, with higher rates of regular ACE inhibitor, beta-blocker and statin intake and no difference regarding aspirin. Cardiovascular rehabilition also brings advantages in the field of psychology, and has demonstrated major improvements in depression, anxiety, hostility, somatisation and quality of life. These improvements may be more evident in younger patients, who usually have more adverse psychological and classic risk profiles. 35, 36 Although difficult to achieve in clinical practice, smoking cessation is a priority after ACS as it has the most relevant isolated survival benefit compared with each group of drugs and each secondary prevention measure. 18 The Prospective Registry Evaluating Myocardial Infarction:
Events and Recovery (PREMIER), 37 with a population of 2,498 patients from 19 US centres, verified that only 46% of patients who were previous smokers had quit smoking six months after ACS and found that individual smoking cessation counselling was not effective enough to reach the goal. By multivariate analysis, referral to cardiac rehabilitation and a smoking cessation programme in hospital were identified as the only factors related to smoking cessation.
Conclusion
Cardiac rehabilitation, a comprehensive approach to the management of post-ACS patients, may be considered the best known secondary prevention programme since it has repeatedly demonstrated important reductions in all-cause and cardiovascular mortality in modern populations submitted to the most recent revascularisation techniques and drug regimes. These benefits can be explained by the positive effects of regular aerobic training and behaviour changes that are voluntarily adopted in the acute phase and maintained in the long term.
Educating patients and partners about cardiovascular topics makes them understand that CAD is controllable by implementing long-term lifestyle changes and lifetime drug therapy. To achieve healthy lifestyle changes and aderence to the drug regime, it is vital that the treating cardiologist (the best option) and other team
Cardiac Rehabilitation Kotseva et al., 2009. 8 members address the patient and family members in the very first moments after an ACS or revascularisation, advising them to join a cardiac rehabilitation programme to obtain a better quality of life and longer survival.
This lifetime intervention is not easily sustainable because, due to modern therapies, many patients are sedentary and fully revascularised and do not experience any limitation after the ACS.
Only through an information and education programme will it be possible to make them understand the need to keep taking the medication and maintain a healthy lifestyle in the long term.
The individual and group approach promoted in cardiac rehabilitation programmes has already proved to be the best intervention to change the mind of reluctant patients and make them understand that it is important to respect the evidence-based drug regimes. This finding, by itself, is a collateral and additional gain inherent to cardiac rehabilitation. n
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